References
- 1. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016; 26: 1343-1421.
- 2. Tun NN, Beckett G, Zammitt NN, et al. Thyrotropin receptor antibody levels at diagnosis and after thionamide course predict Graves’ Disease relapse. Thyroid 2016; 26: 1004-1009.
- 3. Sahlmann CO, Siefker U, Lehmann K, et al. Quantitative thyroid scintigraphy for the differentiation of Graves’ disease and hyperthyroid autoimmune thyroiditis. Nuklearmedizin 2004; 43: 124-128.
- 4. Gilmour J, Brownlee Y, Foster P, et al. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto’s disease, Graves’ disease and a follow-up study on postpartum thyroid disease. Clin Lab 2000; 46: 57-61.
- 5. McLachlan SM, Rapoport B. Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid 2004; 14: 510-520.
- 6. Ogawa T, Sakata S, Nakamura S, et al. Thyroid hormone autoantibodies in patients with Graves’ disease: effect of antithyroid drug treatment. Clin Chim Acta 1994; 228: 113-122.
- 7. Gerenova JB, Vulkov Y, Boeva S, Halacheva K. Diagnostic and prognostic value of antithyroid antibodies and serum thyroglobulin levels during treatment of Graves’ disease with Methimazole. J Endocrinologia 2001; 6: 16-18.
- 8. Goh SY, Ho SC, Seah LL, Fong KS, Khoo DH. Thyroid auto-antibody profiles in ophthalmic dominant and thyroid dominant Graves’ disease differ and suggest ophthalmopathy is a multiantigenic disease. Clin Endocrinol (Oxf) 2004; 60: 600-607.
- 9. Khoo DH, Ho SC, Seah LL, et al. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves’ disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid 1999; 9: 1175-1180.
- 10. Wright-Pascoe R, Smikle MF, Barton EN, James OB. Limited usefulness of antithyroperoxidase and antithyroglobulin assays in Jamaicans with Graves’ disease. Hum Antibodies 1999; 9: 161-164.
- 11. Alnaqdy A, Al-Maskari M. Determination of the levels of antithyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves’ disease. Med Princ Pract 2005; 14: 209-212.
- 12. Lantz M, Planck T, Asman P, Hallengren B. Increased TRAb and/or low anti-TPO titers at diagnosis of graves’ disease are associated with an increased risk of developing ophthalmopathy after onset. Exp Clin Endocrinol Diabetes 2014; 122: 113-117.
- 13. Lastrzebska-Bohaterewicz E, Wojciechowska W, Gardas A. Place of thyroglobulin antibodies assay in laboratory diagnostic of autoimmune thyroid diseases. Endokrynol Pol 2005; 56: 30-34.
- 14. Schott M, Eckstein A, Willenberg HS, Nguyen TB, Morgenthaler NG, Scherbaum WA. Improved prediction of relapse of Graves’ thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies. Horm Metab Res 2007; 39: 56-61.
- 15. Goichot B, Bouée S, Castello-Bridoux C, Caron P. Survey of clinical practice patterns in the management of 992 hyperthyroid patients in France. Eur Thyroid J 2017; 6: 152-159.
- 16. Laurberg P, Nygaard B, Andersen S, et al. Association between TSH-receptor autoimmunity, hyperthyroidism, goitre, and orbitopathy in 208 patients included in the Remission Induction and Sustenance in Graves’ Disease Study. J Thyroid Res 2014;2014:165487.
- 17. Boyanov M, Bakalov D, Sheinkova G. Levels of thyroid auto-antibodies in patients with Graves Disease and Graves Ophtalmopathy. Turk J Endocrinol Metab 2010; 14: 50-53.
- 18. Lee JH, Park SH, Koh DG, Suh BK. Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves’ ophthalmopathy. World J Pediatr 2014; 10: 155-159.
- 19. Komaki T, Sakata S, Nakamura S, et al. Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves’ disease during long-term treatment period. Nihon Naibunpi Gakkai Zasshi 1989; 65: 627-639.
- 20. Marinò M, Chiovato L, Lisi S, et al. Role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy: the hypothesis of Kriss revisited. J Endocrinol Invest 2004; 27: 230-236.
- 21. Shanmuganathan T, Girgis C, Lahooti H, et al. Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves’ ophthalmopathy: a review. Clin Ophthalmol 2015; 9: 2271-2276.
- 22. Brunn J, Block U, Ruf G, et al. Volumetrie der schilddrüse mittels Real-time-sonographie. Deutsche Medizinische Wochenschrift 1981; 106: 1338-1340.
- 23. Niedziela M, Warzywoda M, Korman E. Thyroid echogeneity as a useful tool for the differential diagnosis of hyperthyroidism in the course of Graves disease and Hashimoto thyroiditis. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2000; 6: 143-150.
- 24. Sahlmann CO, Siefker U, Lehmann K, et al. Quantitative thyroid scintigraphy for the differentiation of Graves’ disease and hyperthyroid autoimmune thyroiditis. Nuklearmedizin 2004; 43: 124-128.
- 25. Bartalena L, Baldeschi L, Dickinson AJ, et al. Consensus statement of the European group on Graves’ orbitopathy (EUGOGO) on management of Graves’ orbitopathy. Thyroid 2008; 18: 333-346.
- 26. Chardès T, Chapal N, Bresson D, et al. The human anti-thyroid peroxidase autoantibody repertoire in Graves’ and Hashimoto’s autoimmune thyroid diseases. Immunogenetics 2002; 54: 141-157.
- 27. Gardas A, Lewartowska A, Sutton BJ, et al. Human thyroid peroxidase (TPO) isoforms, TPO-1 and TPO-2: analysis of protein expression in Graves’ thyroid tissue. J Clin Endocrinol Metab 1997; 82: 3752-3757.
- 28. Bossowski A, Stasiak-Barmuta A, Czarnocka B, et al. Application of mouse monoclonal antibodies for identification of antigen regions of human thyroid peroxidase in adolescents with Graves’ disease and non-toxic multinodular goiter by flow cytometry. Autoimmunity 2005; 38: 605-611.
- 29. Zhyzhneuskaya S, Addison C, Tsatlidis V, et al. The Natural history of subclinical hyperthyroidism in Graves’ Disease: The rule of thirds. Thyroid 2016; 26: 765-769.
- 30. Hu YM, Liu W, Lu GH. Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves’s disease and Hashimoto’s hyperthyroidism. Zhonghua Yi Xue Za Zhi 2003; 83: 940-942.
- 31. Lima, PC, Moura Neto A, Tambascia MA, Zantut Wittmann DE. Risk factors associated with benign and malignant thyroid nodules in autoimmune thyroid diseases. ISRN Endocrinol 2013: 673146. DOI: 10.1155/2013/673146.
- 32. Scherer T, Wohlschlaeger-Krenn E, Bayerle-Eder M, et al. A case of simultaneous occurrence of Marine – Lenhart syndrome and a papillary thyroid microcarcinoma. BMC Endocr Disord 2013; 13: 16.
- 33. Goh SY, Ho SC, Seah LL, et al. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves’ disease differ and suggest ophthalmopathy is a multiantigenic disease. Clin Endocrinol (Oxf) 2004; 60: 600-607.
- 34. Khoo DH, Eng PH, Ho SC, et al. Graves’ ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid 2000; 10: 1093-1100.
- 35. Lai OF, Zaiden N, Goh SS, et al. Detection of thyroid peroxidase mRNA and protein in orbital tissue. Eur J Endocrinol 2006; 155: 213-218.
- 36. Molnár I, Szentmiklósi JA, Somogyiné-Vári É. Hyperthyroidism in patients with Graves’ ophthalmopathy, and thyroidal, skeletal and eye muscle specific type 2 deiodinase enzyme activities. Exp Clin Endocrinol Diabetes 2017; 125: 514-521.
- 37. Segundo C, Rodríguez C, Aguilar M, et al. Differences in thyroid-infiltrating B lymphocytes in patients with Graves’ disease: relationship to autoantibody detection. Thyroid 2004; 14: 337-344.
- 38. Vos XG, Endert E, Zwinderman AH, et al. Predicting the risk of recurrence before the start of antithyroid drug therapy in patients with Graves’ hyperthyroidism. J Clin Endocrinol Metab 2016; 101: 1381-1389.
- 39. Marinò M, Lisi S, Pinchera A, et al. Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy. Thyroid 2001; 11: 177-185.
- 40. Konishi J, Herman MM, Kriss JP. Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology 1974; 95: 434-446.
- 41. Endo T, Kobayashi T. Immunization with thyroglobulin induces Graves’-like disease in mice. J Endocrinol 2009; 202: 217-22.
- 42. Kampmann E, Diana T, Kanitz M, Hoppe D, Kahaly GJ. Thyroid stimulating but not blocking autoantibodies are highly prevalent in severe and active thyroid-associated orbitopathy: A prospective study. Int J Endocrinol 2015:678194.